Judy Glynn
judy.k.glynn@pfizer.com
Judy Glynn is senior principal scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
|
Advances in Monoclonal Antibody Purification
March 2, 2010
By:
Judy Glynn
,
Denis Boyle, PhD
,
Jay Wealand
,
Erin Miller-Cary
,
Brian Chen
,
Paul Mensah, PhD
New technologies and adaptations of existing technologies can improve platform processes.
|
The Development and Application of a Monoclonal Antibody Purification Platform
October 2, 2009
By:
Judy Glynn
,
Timothy Hagerty
,
Timothy Pabst, PhD
,
Gopinath Annathur
,
Kristin Thomas
,
Paul Johnson
,
Natarajan Ramasubramanyan, PhD
,
Paul Mensah, PhD
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
|
The Development and Application of a Monoclonal Antibody Purification Platform
March 2, 2009
By:
Judy Glynn
,
Timothy Hagerty
,
Timothy Pabst, PhD
,
Gopinath Annathur
,
Kristin Thomas
,
Paul Johnson
,
Natarajan Ramasubramanyan, PhD
,
Paul Mensah, PhD
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
|
|
